Host immune modulation by antimicrobial drugs: current knowledge and implications for antimicrobial chemotherapy

Curr Opin Pharmacol. 2014 Oct:18:159-66. doi: 10.1016/j.coph.2014.07.011. Epub 2014 Sep 5.

Abstract

It is known that antimicrobial agents possess several, beneficial, secondary properties which complement their primary antimicrobial activity like the immunomodulatory capacity that enforces host defense mechanisms or reduces host inflammatory response. In this review the current state of our recent research about the interaction between some antimicrobial agents and the immune system as complex pyramid of redundant cellular factors, humoral effectors and mediators against various microbial pathogens, will be presented and compared with recent literature data. The nature of such interactions is diverse and depends on the drug, the host immunological status and the microorganism. A more complete understanding of the host immune modulation by antimicrobial drugs may guide the selection of appropriate regimens for given clinical situations.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Antifungal Agents / pharmacology*
  • Candida albicans / drug effects
  • Candida glabrata / drug effects
  • Escherichia coli / drug effects
  • Humans
  • Immunologic Factors / pharmacology*
  • Neutrophils / drug effects*
  • Neutrophils / immunology
  • Pseudomonas aeruginosa / drug effects
  • Streptococcus pyogenes / drug effects

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Immunologic Factors